Memorial Sloan Kettering Cancer Center
The purpose of this study is to develop and test a new communication training intervention called Hematolo-GIST to help oncologists communicate with patients about their lymphoma diagnosis and advance care planning.
Inclusion Criteria: Providers * Currently a an MSK provider caring for patients with DLBCL (including DLBCL-transformed follicular lymphoma (TFL) and primary mediastinal B-cell lymphoma (PMBCL) which are histologically similar and treated as large-cell lymphoma) Patients * Per medical record, is currently being treated by a provider who is participating in this study (for the purposes of this study, "treating provider" will be defined as any provider who provides care related to the patient's lymphoma diagnosis) * Per medical record, has a diagnosis of DLBCL including DLBCL-transformed fol…
Hematologist will participate in a group Hematolo-GIST training provided remotely via the study team.
Participants will meet with Hematolo-GIST trained hematologists. Participants will consent to having their appointment audio-recorded on password-protected devices or MSK approved secure platforms.
Arctuva estimate
Verify or correct the compensation shown for this listing.